222

KYONGBO PHARMACEUTICAL CO., LTD.

No trades
See on Supercharts
Market capitalization
‪177.87 B‬KRW
‪2.97 B‬KRW
‪216.36 B‬KRW
‪19.82 M‬
Beta (1Y)
1.27
Employees (FY)
514
Change (1Y)
+23 +4.68%
Revenue / Employee (1Y)
‪323.27 K‬KRW
Net income / Employee (1Y)
‪4.44 K‬KRW

About KYONGBO PHARMACEUTICAL CO., LTD.


CEO
Tae-Young Kim
Headquarters
Asan-si
Founded
1987
ISIN
KR7214390007
FIGI
BBG008QGFS64
KYONGBO PHARMACEUTICAL Co., Ltd. engages in the manufacture and sale of pharmaceutical products. Its products include general, antibiotic, and anticancer active pharmaceutical ingredients, inhalation anesthetics, cefaclor capsules, and cefaclor dried syrups. The company was founded on March 31, 1987 and is headquartered in Asan-si, South Korea.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 214390 is 7,440 KRW — it has decreased by −2.75% in the past 24 hours. Watch KYONGBO PHARMACEUTICAL CO., LTD. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange KYONGBO PHARMACEUTICAL CO., LTD. stocks are traded under the ticker 214390.
214390 reached its all-time high on Jun 29, 2015 with the price of 38,500 KRW, and its all-time low was 4,580 KRW and was reached on Mar 19, 2020. View more price dynamics on 214390 chart.
See other stocks reaching their highest and lowest prices.
214390 stock is 7.39% volatile and has beta coefficient of 1.27. Track KYONGBO PHARMACEUTICAL CO., LTD. stock price on the chart and check out the list of the most volatile stocks — is KYONGBO PHARMACEUTICAL CO., LTD. there?
Yes, you can track KYONGBO PHARMACEUTICAL CO., LTD. financials in yearly and quarterly reports right on TradingView.
214390 net income for the last quarter is ‪1.08 B‬ KRW, while the quarter before that showed ‪156.52 M‬ KRW of net income which accounts for 590.67% change. Track more KYONGBO PHARMACEUTICAL CO., LTD. financial stats to get the full picture.
KYONGBO PHARMACEUTICAL CO., LTD. dividend yield was 0.60% in 2023, and payout ratio reached 40.19%. The year before the numbers were 0.50% and 195.77% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 10, 2024, the company has 514.00 employees. See our rating of the largest employees — is KYONGBO PHARMACEUTICAL CO., LTD. on this list?
Like other stocks, 214390 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade KYONGBO PHARMACEUTICAL CO., LTD. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So KYONGBO PHARMACEUTICAL CO., LTD. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating KYONGBO PHARMACEUTICAL CO., LTD. stock shows the sell signal. See more of KYONGBO PHARMACEUTICAL CO., LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.